{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:20:52Z","timestamp":1793298052861,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease and related dementia (ADRD) represents a growing public health burden, especially in low- and middle-income countries. Yet, most studies focus on Non-Hispanic white (NHW) populations from high-income countries. This study investigates plasma proteomic signatures associated with amyloid pathology in African populations. Nigerian older adults from the VALIANT study and participants from a Tanzanian study, with available biomarker quantification in plasma are employed. For proteomic comparison, participants from the Canadian TRIAD cohort are included, capturing a distinct population. Here, we show that multiple proteins are differentially abundant in the plasma of p-tau217-positive individuals and in the different cognitive groups, with findings largely consistent amongst African cohorts. Comorbidities are significantly associated with protein levels and differences in plasma biomarkers levels are found between sexes. Lastly, VALIANT and TRIAD show both shared and unique protein profiles in relation to amyloid-pathology. These findings support the utility of fluid biomarkers in ADRD in African populations.<\/jats:p>","DOI":"10.1038\/s41467-026-74971-4","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:23:17Z","timestamp":1782944597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma proteomic profiles of Alzheimer\u2019s disease and neurodegeneration in African cohorts"],"prefix":"10.1038","volume":"17","author":[{"given":"Ilaria","family":"Pola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope","family":"Akinyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-3545","authenticated-orcid":false,"given":"Oladotun","family":"Olalusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Traichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Giacomucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Yaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6986-964X","authenticated-orcid":false,"given":"Gabriel","family":"Ogunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olabode","family":"Oguntiloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayotomiwa","family":"Fagbemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eniola","family":"Cadmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femi","family":"Popoola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella-Maria","family":"Paddick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dotchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyoce","family":"Kisoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-122X","authenticated-orcid":false,"given":"Richard","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayowa","family":"Ogunronbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Olujobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaoluwa","family":"Famuyiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Akinyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayowa","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7357-4692","authenticated-orcid":false,"given":"Chinedu T.","family":"Udeh\u2013Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-1426","authenticated-orcid":false,"given":"Olusola","family":"Ladokun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1925-7810","authenticated-orcid":false,"given":"Anthony","family":"Griswold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-7447","authenticated-orcid":false,"given":"Roman","family":"Romero-Ortuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-8804","authenticated-orcid":false,"given":"Margaret","family":"Pericak-Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adesola","family":"Ogunniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Debette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-4923","authenticated-orcid":false,"given":"Rajesh","family":"Kalaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus O.","family":"Akinyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-1741","authenticated-orcid":false,"given":"Andrea L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"74971_CR1","unstructured":"Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, 105\u2013125 (2022)."},{"key":"74971_CR2","unstructured":"Prince MJea. World Alzheimer Report 2015-The Global Impact of Dementia: an analysis of prevalence, incidence, cost and trends. (World Alzheimer Report, 2015)."},{"key":"74971_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/alz.12432","volume":"18","author":"RO Akinyemi","year":"2022","unstructured":"Akinyemi, R. O. et al. Dementia in Africa: current evidence, knowledge gaps, and future directions. Alzheimers Dement 18, 790\u2013809 (2022).","journal-title":"Alzheimers Dement"},{"key":"74971_CR4","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1002\/alz.13836","volume":"20","author":"R Kalaria","year":"2024","unstructured":"Kalaria, R. et al. The 2022 symposium on dementia and brain aging in low- and middle-income countries: highlights on research, diagnosis, care, and impact. Alzheimers Dement 20, 4290\u20134314 (2024).","journal-title":"Alzheimers Dement"},{"key":"74971_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1474-4422(22)00475-6","volume":"22","author":"RO Akinyemi","year":"2023","unstructured":"Akinyemi, R. O. et al. The African dementia consortium. Lancet Neurol. 22, 28\u201329 (2023).","journal-title":"Lancet Neurol."},{"key":"74971_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41582-025-01125-3","volume":"21","author":"RF Allegri","year":"2025","unstructured":"Allegri, R. F. Dementia research in low-income and middle-income countries - a view from Latin America. Nat. Rev. Neurol. 21, 499\u2013505 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"74971_CR7","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz, C. et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E \u03f54,and the risk of late-onset Alzheimer disease in African Americans. JAMA 309, 1483\u20131492 (2013).","journal-title":"JAMA"},{"key":"74971_CR8","doi-asserted-by":"publisher","first-page":"e1009977","DOI":"10.1371\/journal.pgen.1009977","volume":"18","author":"F Rajabli","year":"2022","unstructured":"Rajabli, F. et al. A locus at 19q13.31 significantly reduces the ApoE epsilon4 risk for Alzheimer\u2019s Disease in African Ancestry. PLoS Genet 18, e1009977 (2022).","journal-title":"PLoS Genet"},{"key":"74971_CR9","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","volume":"111","author":"H Hampel","year":"2023","unstructured":"Hampel, H. et al. Blood-based biomarkers for Alzheimer\u2019s disease: current state and future use in a transformed global healthcare landscape. Neuron 111, 2781\u20132799 (2023).","journal-title":"Neuron"},{"key":"74971_CR10","unstructured":"Cruchaga, C. et al. Large-scale plasma proteomic profiling unveils novel diagnostic biomarkers and pathways for Alzheimer\u2019s disease. Res Sq 2025."},{"key":"74971_CR11","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","volume":"27","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette, A. et al. Proteomic changes in Alzheimer\u2019s disease associated with progressive Abeta plaque and tau tangle pathologies. Nat. Neurosci. 27, 1880\u20131891 (2024).","journal-title":"Nat. Neurosci."},{"key":"74971_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14367","volume":"21","author":"AJ Griswold","year":"2025","unstructured":"Griswold, A. J. et al. Generalizability of tau and amyloid plasma biomarkers in Alzheimer\u2019s disease cohorts of diverse genetic ancestries. Alzheimers Dement 21, e14367 (2025).","journal-title":"Alzheimers Dement"},{"key":"74971_CR13","doi-asserted-by":"crossref","unstructured":"Ikanga, J. et al. Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer\u2019s Disease in Kinshasa, Democratic Republic of Congo. medRxiv 2024.","DOI":"10.1101\/2024.09.03.24313019"},{"key":"74971_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1477047","volume":"16","author":"J Ikanga","year":"2024","unstructured":"Ikanga, J. et al. Preliminary reference values for Alzheimer\u2019s disease plasma biomarkers in Congolese individuals with and without dementia. Front. Aging Neurosci. 16, 1477047 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"74971_CR15","volume":"15","author":"J Ikanga","year":"2023","unstructured":"Ikanga, J. et al. Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo. Alzheimers Dement 15, e12496 (2023).","journal-title":"Alzheimers Dement"},{"key":"74971_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/13872877251394384","volume":"109","author":"VA Ucheagwu","year":"2026","unstructured":"Ucheagwu, V. A. et al. Alzheimer\u2019s Disease Biomarker-Nigeria (ADIBIO-N): Cohort description and baseline data report. J. Alzheimers Dis. 109, 433\u2013446 (2026).","journal-title":"J. Alzheimers Dis."},{"key":"74971_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71164","volume":"22","author":"C Yang","year":"2026","unstructured":"Yang, C. et al. Analyses of plasma multi-omic data across ancestries identify novel pathways implicated in Alzheimer\u2019s disease. Alzheimers Dement 22, e71164 (2026).","journal-title":"Alzheimers Dement"},{"key":"74971_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-023-00638-z","volume":"18","author":"ES Modeste","year":"2023","unstructured":"Modeste, E. S. et al. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer\u2019s disease. Mol. Neurodegener. 18, 48 (2023).","journal-title":"Mol. Neurodegener."},{"key":"74971_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.11604\/pamj.2021.38.112.28180","volume":"38","author":"JJ Noubiap","year":"2021","unstructured":"Noubiap, J. J. Clustering of cardiometabolic risk factors in sub-Saharan Africans. Pan Afr. Med J. 38, 112 (2021).","journal-title":"Pan Afr. Med J."},{"key":"74971_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1017\/S1041610210001390","volume":"23","author":"A Ogunniyi","year":"2011","unstructured":"Ogunniyi, A. et al. Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study. Int. Psychogeriatr. 23, 387\u2013394 (2011).","journal-title":"Int. Psychogeriatr."},{"key":"74971_CR21","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1474-4422(12)70205-3","volume":"11","author":"LA Benjamin","year":"2012","unstructured":"Benjamin, L. A. et al. HIV infection and stroke: current perspectives and future directions. Lancet Neurol. 11, 878\u2013890 (2012).","journal-title":"Lancet Neurol."},{"key":"74971_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/tmi.13151","volume":"23","author":"N Bouscaren","year":"2018","unstructured":"Bouscaren, N. et al. Prevalence of toxoplasmosis and its association with dementia in older adults in Central Africa: a result from the EPIDEMCA programme. Trop. Med. Int. Health 23, 1304\u20131313 (2018).","journal-title":"Trop. Med. Int. Health"},{"key":"74971_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"74971_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"74971_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","volume":"24","author":"J Therriault","year":"2025","unstructured":"Therriault, J. et al. Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 24, 740\u2013752 (2025).","journal-title":"Lancet Neurol."},{"key":"74971_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet 54, 412\u2013436 (2022).","journal-title":"Nat. Genet"},{"key":"74971_CR27","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet, A. L. et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 78, 1471\u20131483 (2021).","journal-title":"JAMA Neurol."},{"key":"74971_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson, N., Andreasson, U., Zetterberg, H. & Blennow, K. Alzheimer\u2019s disease neuroimaging I. Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease. JAMA Neurol. 74, 557\u2013566 (2017).","journal-title":"JAMA Neurol."},{"key":"74971_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70166","volume":"21","author":"RE Rea Reyes","year":"2025","unstructured":"Rea Reyes, R. E. et al. Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer\u2019s disease and related dementias. Alzheimer's Dement 21, e70166 (2025).","journal-title":"Alzheimer's Dement"},{"key":"74971_CR30","doi-asserted-by":"crossref","unstructured":"Gong, K. et al. High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer\u2019s disease phenotypes in a large mixed dementia cohort. Res Sq 2025.","DOI":"10.21203\/rs.3.rs-6440485\/v1"},{"key":"74971_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf004","volume":"7","author":"YT Wang","year":"2025","unstructured":"Wang, Y. T. et al. Identify biological Alzheimer\u2019s disease using a novel nucleic acid-linked protein immunoassay. Brain Commun. 7, fcaf004 (2025).","journal-title":"Brain Commun."},{"key":"74971_CR32","doi-asserted-by":"crossref","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer disease. Nat. Rev. Immunol. 25, 321\u2013352 (2024).","DOI":"10.1038\/s41577-024-01104-7"},{"key":"74971_CR33","doi-asserted-by":"crossref","unstructured":"Park, J. H. et al. Altered TIMP-3 levels in the cerebrospinal fluid and plasma of patients with Alzheimer\u2019s disease. J. Pers. Med. 12, 827 (2022).","DOI":"10.3390\/jpm12050827"},{"key":"74971_CR34","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.neuron.2025.02.014","volume":"113","author":"M Ali","year":"2025","unstructured":"Ali, M. et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. Neuron 113, 1363\u20131379.e1369 (2025).","journal-title":"Neuron"},{"key":"74971_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ana.24573","volume":"79","author":"C Capone","year":"2016","unstructured":"Capone, C. et al. Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice. Ann. Neurol. 79, 387\u2013403 (2016).","journal-title":"Ann. Neurol."},{"key":"74971_CR36","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s43587-025-00965-4","volume":"5","author":"S Afshar","year":"2025","unstructured":"Afshar, S. et al. Plasma proteomic associations with Alzheimer\u2019s disease endophenotypes. Nat. Aging 5, 2104\u20132124 (2025).","journal-title":"Nat. Aging"},{"key":"74971_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbi.2024.07.002","volume":"120","author":"MR Duggan","year":"2024","unstructured":"Duggan, M. R. et al. Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression. Brain Behav. Immun. 120, 604\u2013619 (2024).","journal-title":"Brain Behav. Immun."},{"key":"74971_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fnagi.2017.00320","volume":"9","author":"M Guglielmotto","year":"2017","unstructured":"Guglielmotto, M. et al. The decrease of Uch-L1 activity is a common mechanism responsible for abeta 42 accumulation in Alzheimer\u2019s and Vascular disease. Front Aging Neurosci. 9, 320 (2017).","journal-title":"Front Aging Neurosci."},{"key":"74971_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000447239","volume":"6","author":"A Ohrfelt","year":"2016","unstructured":"Ohrfelt, A. et al. Increased cerebrospinal fluid levels of ubiquitin carboxyl-terminal hydrolase L1 in patients with Alzheimer\u2019s disease. Dement Geriatr. Cogn. Dis. Extra 6, 283\u2013294 (2016).","journal-title":"Dement Geriatr. Cogn. Dis. Extra"},{"key":"74971_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106356","volume":"189","author":"AL Wojdala","year":"2023","unstructured":"Wojdala, A. L. et al. Trajectories of CSF and plasma biomarkers across Alzheimer\u2019s disease continuum: disease staging by NF-L, p-tau181, and GFAP. Neurobiol. Dis. 189, 106356 (2023).","journal-title":"Neurobiol. Dis."},{"key":"74971_CR41","doi-asserted-by":"publisher","first-page":"e0002677","DOI":"10.1371\/journal.pgph.0002677","volume":"3","author":"AJ Price","year":"2023","unstructured":"Price, A. J. et al. Epidemiology of multimorbidity in low-income countries of sub-Saharan Africa: findings from four population cohorts. PLoS Glob. Public Health 3, e0002677 (2023).","journal-title":"PLoS Glob. Public Health"},{"key":"74971_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bjorkhem","year":"2004","unstructured":"Bjorkhem, I. & Meaney, S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb. Vasc. Biol. 24, 806\u2013815 (2004).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"74971_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-neuro-091922-034237","volume":"46","author":"G Saher","year":"2023","unstructured":"Saher, G. Cholesterol metabolism in aging and age-related disorders. Annu Rev. Neurosci. 46, 59\u201378 (2023).","journal-title":"Annu Rev. Neurosci."},{"key":"74971_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1749-6632.1997.tb48478.x","volume":"826","author":"RN Kalaria","year":"1997","unstructured":"Kalaria, R. N. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer\u2019s disease. Ann. N. Y Acad. Sci. 826, 263\u2013271 (1997).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"74971_CR45","first-page":"1435","volume":"137","author":"M Kawai","year":"1990","unstructured":"Kawai, M., Kalaria, R. N., Harik, S. I. & Perry, G. The relationship of amyloid plaques to cerebral capillaries in Alzheimer\u2019s disease. Am. J. Pathol. 137, 1435\u20131446 (1990).","journal-title":"Am. J. Pathol."},{"key":"74971_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(92)91686-9","volume":"592","author":"M Kawai","year":"1992","unstructured":"Kawai, M., Cras, P. & Perry, G. Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution. Brain Res. 592, 278\u2013282 (1992).","journal-title":"Brain Res."},{"key":"74971_CR47","doi-asserted-by":"crossref","unstructured":"Bertran-Cobo, C. et al. Plasmodium knowlesi infection is associated with elevated circulating biomarkers of brain injury and endothelial activation. medRxiv 2024.","DOI":"10.1101\/2024.04.25.24306382"},{"key":"74971_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41582-021-00579-5","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher, B. M., Tansey, M. G., Dorothee, G. & Heneka, M. T. Publisher Correction: peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat. Rev. Neurol. 17, 724 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"74971_CR49","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","volume":"21","author":"PN Sipila","year":"2021","unstructured":"Sipila, P. N. et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect. Dis. 21, 1557\u20131567 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"74971_CR50","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1111\/j.1582-4934.2012.01556.x","volume":"16","author":"H Sarlus","year":"2012","unstructured":"Sarlus, H. et al. Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation. J. Cell Mol. Med. 16, 2401\u20132412 (2012).","journal-title":"J. Cell Mol. Med."},{"key":"74971_CR51","doi-asserted-by":"crossref","unstructured":"Health in Africa. Nat. Commun. 15, 967 (2024).","DOI":"10.1038\/s41467-024-45268-1"},{"key":"74971_CR52","doi-asserted-by":"crossref","unstructured":"Martinez-Dubarbie, F. et al. Influence of physiological variables and comorbidities on plasma Abeta40, Abeta42, and p-tau181 levels in cognitively unimpaired individuals. Int. J. Mol. Sci. 25, 1581 (2024).","DOI":"10.3390\/ijms25031481"},{"key":"74971_CR53","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/alz.12466","volume":"18","author":"JA Syrjanen","year":"2022","unstructured":"Syrjanen, J. A. et al. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities. Alzheimers Dement 18, 1128\u20131140 (2022).","journal-title":"Alzheimers Dement"},{"key":"74971_CR54","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/s41380-024-02753-9","volume":"30","author":"C Vila-Castelar","year":"2025","unstructured":"Vila-Castelar, C. et al. Sex\/gender effects of glial reactivity on preclinical Alzheimer\u2019s disease pathology. Mol. Psychiatry 30, 1430\u20131439 (2025).","journal-title":"Mol. Psychiatry"},{"key":"74971_CR55","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1038\/s41380-022-01675-8","volume":"27","author":"AA Tsiknia","year":"2022","unstructured":"Tsiknia, A. A. et al. Sex differences in plasma p-tau181 associations with Alzheimer\u2019s disease biomarkers, cognitive decline, and clinical progression. Mol. Psychiatry 27, 4314\u20134322 (2022).","journal-title":"Mol. Psychiatry"},{"key":"74971_CR56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti, M. T. et al. Sex differences in Alzheimer disease - the gateway to precision medicine. Nat. Rev. Neurol. 14, 457\u2013469 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"74971_CR57","doi-asserted-by":"crossref","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer\u2019s disease pathology. medRxiv 2023.","DOI":"10.1101\/2023.07.11.23292493"},{"key":"74971_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-025-09841-y","volume":"650","author":"D Aarsland","year":"2026","unstructured":"Aarsland, D. et al. Prevalence of Alzheimer\u2019s disease pathology in the community. Nature 650, 182\u2013186 (2026).","journal-title":"Nature"},{"key":"74971_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","volume":"79","author":"WJ Jansen","year":"2022","unstructured":"Jansen, W. J. et al. Prevalence estimates of amyloid abnormality across the alzheimer disease clinical spectrum. JAMA Neurol. 79, 228\u2013243 (2022).","journal-title":"JAMA Neurol."},{"key":"74971_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70669","volume":"21","author":"RO Akinyemi","year":"2025","unstructured":"Akinyemi, R. O. et al. Association between cardiovascular and cognitive health among older Indigenous Africans: data from an urban Nigerian settlement participating in the VALIANT study. Alzheimers Dement 21, e70669 (2025).","journal-title":"Alzheimers Dement"},{"key":"74971_CR61","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/gps.4415","volume":"31","author":"WK Gray","year":"2016","unstructured":"Gray, W. K. et al. Community validation of the IDEA study cognitive screen in rural Tanzania. Int J. Geriatr. Psychiatry 31, 1199\u20131207 (2016).","journal-title":"Int J. Geriatr. Psychiatry"},{"key":"74971_CR62","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/gps.3880","volume":"28","author":"AR Longdon","year":"2013","unstructured":"Longdon, A. R. et al. The prevalence of dementia in rural Tanzania: a cross-sectional community-based study. Int J. Geriatr. Psychiatry 28, 728\u2013737 (2013).","journal-title":"Int J. Geriatr. Psychiatry"},{"key":"74971_CR63","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jagp.2014.12.005","volume":"23","author":"SM Paddick","year":"2015","unstructured":"Paddick, S. M. et al. Mild Cognitive Impairment in Rural Tanzania: prevalence, profile, and outcomes at 4-year follow-up. Am. J. Geriatr. Psychiatry 23, 950\u2013959 (2015).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"74971_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70171","volume":"21","author":"I Pola","year":"2025","unstructured":"Pola, I. et al. Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer\u2019s disease. Alzheimers Dement 21, e70171 (2025).","journal-title":"Alzheimers Dement"},{"key":"74971_CR65","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/0891988714522695","volume":"27","author":"WK Gray","year":"2014","unstructured":"Gray, W. K. et al. Development and validation of the identification and intervention for dementia in Elderly Africans (IDEA) study dementia screening instrument. J. Geriatr. Psychiatry Neurol. 27, 110\u2013118 (2014).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"74971_CR66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12877-015-0040-1","volume":"15","author":"SM Paddick","year":"2015","unstructured":"Paddick, S. M. et al. Validation of the Identification and Intervention for Dementia in Elderly Africans (IDEA) cognitive screen in Nigeria and Tanzania. BMC Geriatr. 15, 53 (2015).","journal-title":"BMC Geriatr."},{"key":"74971_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/arclin\/acz086","volume":"36","author":"GM Masika","year":"2021","unstructured":"Masika, G. M., Yu, D. S. F. & Li, P. W. C. Accuracy of the montreal cognitive assessment in detecting mild cognitive impairment and dementia in the rural African population. Arch. Clin. Neuropsychol. 36, 371\u2013380 (2021).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"74971_CR68","doi-asserted-by":"publisher","DOI":"10.3402\/gha.v7.25988","volume":"7","author":"C Collingwood","year":"2014","unstructured":"Collingwood, C. et al. Development and community-based validation of the IDEA study instrumental activities of daily living (IDEA-IADL) questionnaire. Glob. Health Action 7, 25988 (2014).","journal-title":"Glob. Health Action"},{"key":"74971_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H. Jr., Chance, J. M. & Filos, S. Measurement of functional activities in older adults in the community. J. Gerontol. 37, 323\u2013329 (1982).","journal-title":"J. Gerontol."},{"key":"74971_CR70","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1212\/WNL.0000000000011416","volume":"96","author":"J Therriault","year":"2021","unstructured":"Therriault, J. et al. Frequency of biologically defined alzheimer disease in relation to Age, Sex, APOE epsilon4, and cognitive impairment. Neurology 96, e975\u2013e985 (2021).","journal-title":"Neurology"},{"key":"74971_CR71","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2967\/jnumed.120.245209","volume":"62","author":"J Therriault","year":"2021","unstructured":"Therriault, J. et al. Determining Amyloid-beta Positivity Using (18)F-AZD4694 PET Imaging. J. Nucl. Med. 62, 247\u2013252 (2021).","journal-title":"J. Nucl. Med."},{"key":"74971_CR72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement"},{"key":"74971_CR73","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault, J. et al. Association of apolipoprotein E epsilon4 with medial temporal tau independent of amyloid-beta. JAMA Neurol. 77, 470\u2013479 (2020).","journal-title":"JAMA Neurol."},{"key":"74971_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/bio.2017.0113","volume":"16","author":"RO Akinyemi","year":"2018","unstructured":"Akinyemi, R. O. et al. Biobanking in a challenging african environment: unique experience from the SIREN project. Biopreserv Biobank 16, 217\u2013232 (2018).","journal-title":"Biopreserv Biobank"},{"key":"74971_CR75","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/clinchem\/hvaf162","volume":"72","author":"AL Benedet","year":"2026","unstructured":"Benedet, A. L. et al. Diagnostic value of serum p-tau217 in Alzheimer Disease: equal to plasma in levels and clinical utility? Clin. Chem. 72, 303\u2013315 (2026).","journal-title":"Clin. Chem."},{"key":"74971_CR76","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","volume":"5","author":"R Ossenkoppele","year":"2025","unstructured":"Ossenkoppele, R. et al. Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials. Nat. Aging 5, 883\u2013896 (2025).","journal-title":"Nat. Aging"},{"key":"74971_CR77","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","volume":"31","author":"F Imam","year":"2025","unstructured":"Imam, F. et al. The global neurodegeneration proteomics consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging. Nat. Med. 31, 2556\u20132566 (2025).","journal-title":"Nat. Med."},{"key":"74971_CR78","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"74971_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-166","volume":"8","author":"Frohlich","year":"2007","unstructured":"Frohlich et al. GOSim-an R-package for computation of information theoretic GO similarities between terms and gene products. BMC Bioinforma. 8, 166 (2007).","journal-title":"BMC Bioinforma."},{"key":"74971_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle, H., Meirelles, G. V., da Silva, F. R., Telles, G. P. & Minghim, R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinforma. 16, 169 (2015).","journal-title":"BMC Bioinforma."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74971-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:02:31Z","timestamp":1786532551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74971-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74971"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74971-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Enigma, LabCorp, Merck Sharp & Dohme, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, ScandiBio Therapeutics AB, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, LabCorp, Lilly, Novo Nordisk, Oy Medix Biochemica AB, Roche, and WebMD, is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, and is a shareholder of CERimmune Therapeutics (outside submitted work). PRN served as member of Novonordist Advisory Board, Eisai Advisory Board, and Ely Lilly Advisory Board. He receives funding from Weston Brain Institute, Canadian Institutes of Health Research (CIHR), Fonds de Recherche du Qu\u00e9bec \u2013 Sant\u00e9 (FRQS);and Colin J. Adair Charitable Foundation. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8215"}}